TER 10-Q report for 2025-06-29

Teradyne filed Form 10‑Q for quarter ended June 29, 2025. Report includes condensed consolidated financial statements showing six‑month revenue $1,337,477k, six‑month net income $177,269k, cash & equivalents $339,252k, total assets $3,761,862k, and diluted EPS for six months $1.10. Shares outstanding reported at 159,073,532 as of July 28, 2025.

This entry summarizes Teradyne’s Form 10‑Q for the quarter ended June 29, 2025. The filing provides the condensed consolidated balance sheet, statements of operations, comprehensive income, shareholders’ equity, cash flows, and accompanying notes. Key figures: total assets $3,761,862 (in thousands), cash and cash equivalents $339,252 (in thousands), marketable securities (current) $28,638 (in thousands), accounts receivable $433,001 (in thousands), inventories $350,505 (in thousands), total current liabilities $675,265 (in thousands). For the three and six months ended June 29, 2025, total revenues were $651,797 (three months) and $1,337,477 (six months) (in thousands); net income was $78,372 (three months) and $177,269 (six months) (in thousands). Diluted net income per share was $0.49 for the quarter and $1.10 for the six months. Operating cash flow for the six months was $343,726 (in thousands); cash used in investing activities was $240,237 (in thousands), and cash used in financing activities was $313,619 (in thousands). The filing notes 159,073,532 shares outstanding as of July 28, 2025. The provided 10‑Q contains comprehensive financial disclosures and MD&A references but does not by itself create a unique, high‑confidence trading catalyst beyond the reported results; the play outcome is marked as failed and the recommended strategy was sell.

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high‑confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As‑is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk‑factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt of CleanSpark, Inc.’s Form 10‑Q for the quarter ended March 31, 2026 is primarily the cover page. It identifies the filing and describes listed securities (common stock and redeemable warrants with exercise terms) but contains no operating/financial results, guidance, risks, or MD&A that would support a differentiated trading view. Actionability is therefore limited to capital‑structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover‑page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk‑factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.